New cancer clinical trial: Copanlisib and Fulvestrant in Treating Postmenopausal Patients With ER+ and HER2- Metastatic Breast Cancer Progressing After Aromatase and CDK 4/6 Inhibitors Treatment

Published on: January 15, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share